Quantitative Investment Management, LLC Omeros Corp Transaction History

Quantitative Investment Management, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$14.81 - $19.13 $192,737 - $248,957	-13,014 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$14.52 - $23.53 $188,963 - $306,219	13,014 New	13,014 $231,000
Q3 2020 Nov 13, 2020	SELL	$9.57 - $21.32 $120,543 - $268,546	-12,596 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$12.21 - $16.99 $153,797 - $214,006	12,596 New	12,596 $185,000
Q4 2019 Feb 14, 2020	SELL	$13.01 - $17.15 $638,699 - $841,944	-49,093 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$14.55 - $20.56 $56,992 - $80,533	3,917 Added 8.67%	49,093 $801,000
Q2 2019 Aug 14, 2019	BUY	$15.0 - $19.62 $434,220 - $567,959	28,948 Added 178.38%	45,176 $708,000
Q1 2019 May 15, 2019	SELL	$11.65 - $17.72 $317,718 - $483,259	-27,272 Reduced 62.69%	16,228 $281,000
Q4 2018 Feb 12, 2019	BUY	$10.72 - $16.73 $293,728 - $458,402	27,400 Added 170.19%	43,500 $484,000
Q3 2018 Nov 14, 2018	BUY	$17.73 - $26.69 $285,453 - $429,709	16,100 New	16,100 $393,000
Q4 2017 Feb 14, 2018	SELL	$13.26 - $22.86 $1.04 Million - $1.8 Million	-78,600 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$19.76 - $24.9 $1.55 Million - $1.96 Million	78,600	78,600 $1.7 Million

120

25.6M

228K

630K

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $684M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

Get notified when there are updates to the investment portfolio of Quantitative Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Quantitative Investment Management, LLC with notifications on news.